Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRAIL-ID trial of intravenous versus oral iron supplementation in frail elderly patients with cardiovascular disease
2025-521570-34-00Phase 4Authorised
- Sponsor
- Wroclaw Medical University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA), Fragility and cardiac morbidity comparing Intravenous ferric carboxymaltose arm, Oral ferrous sulfate arm and Placebo/control arm (3 arms). Primary endpoint: Change in Short Physical Performance Battery score. Planned start Jun 2026; status: authorised.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
iron deficiency anemia (IDA)Fragilitycardiac morbidity
Beyond the preview
Go deeper on 2025-521570-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521570-34-00.